Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site release/version change without altering the underlying study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 has been added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision tag on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded an optional tag 'Gastric cancer' and a new 'Genetic and Rare Diseases Information Center' resource under Resources. These changes provide additional context but do not modify the trial details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedA new site revision label 'Revision: v3.4.2' has been added. A prior notice about government funding status and operating status (Revision: v3.4.1) is present, but core trial details remain unchanged.SummaryDifference0.5%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.